Rocket Lab USA, Inc. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>Rocket Lab USA, Inc. has filed its Q1 2024 10-Q report, detailing financial performance and asset valuations.</b>

AI Summary

Rocket Lab USA, Inc. (RKLB) filed a Quarterly Report (10-Q) with the SEC on May 6, 2024. Rocket Lab USA, Inc. filed a 10-Q report for the period ending March 31, 2024. The filing includes financial data for the first quarter of 2024. Key financial statement items such as Cost of Sales and Selling, General & Administrative Expenses are reported. Information regarding fair value measurements of various financial instruments is provided for March 31, 2024, and December 31, 2023. The company's fiscal year ends on December 31.

Why It Matters

For investors and stakeholders tracking Rocket Lab USA, Inc., this filing contains several important signals. This 10-Q filing provides investors with the latest quarterly financial snapshot of Rocket Lab USA, Inc., crucial for assessing performance and making investment decisions. The detailed breakdown of financial instruments and their fair values offers insight into the company's asset management and risk exposure.

Risk Assessment

Risk Level: medium — Rocket Lab USA, Inc. shows moderate risk based on this filing. The filing is a standard quarterly report (10-Q), which typically contains routine financial information. However, the aerospace and defense industry is subject to significant market and operational risks not detailed in this header information.

Analyst Insight

Review the full 10-Q filing to analyze revenue trends, cost of sales, operating expenses, and any disclosed risks or forward-looking statements.

Key Numbers

• 2024-03-31 — Reporting Period End Date (Conformed Period of Report)
• 2023-12-31 — Previous Reporting Period End Date (Fair Value Measurements)
• 2024-01-01 — Quarter Start Date (Financial Data Period)
• 2023-01-01 — Prior Year Quarter Start Date (Financial Data Period)

Key Players & Entities

• Rocket Lab USA, Inc. (company) — Filer name
• 0000950170-24-053646 (other) — Accession Number
• 20240331 (date) — Conformed Period of Report
• 20240506 (date) — Filed as of date
• DE (other) — State of Incorporation
• 3881 McGowen Street (other) — Business Address Street 1
• LONG BEACH (other) — Business Address City
• CA (other) — Business Address State

FAQ

Industry Context

Rocket Lab operates in the space launch and aerospace systems industry, a sector characterized by high technological innovation, significant capital investment, and government contracts.

Regulatory Implications

As a publicly traded company, Rocket Lab USA, Inc. is subject to the reporting requirements of the Securities and Exchange Commission (SEC), including the filing of quarterly (10-Q) and annual (10-K) reports.

What Investors Should Do

1. Review the full 10-Q for detailed financial statements, including balance sheets, income statements, and cash flow statements.
2. Analyze the Management's Discussion and Analysis (MD&A) section for insights into the company's performance, strategies, and outlook.
3. Examine the footnotes to the financial statements for critical accounting policies, commitments, contingencies, and other disclosures.

Key Dates

• 2024-03-31: Quarterly Period End — End of the reporting period for the 10-Q filing.
• 2024-05-06: Filing Date — Date the 10-Q report was officially filed with the SEC.

Year-Over-Year Comparison

This is the Q1 2024 10-Q filing, following the Q4 2023 10-K filing. Specific comparative data between this filing and the prior year's Q1 10-Q is not available in the provided header.

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share RKLB The Nasdaq Stock Mar

Filing Documents

• rklb-20240331.htm (10-Q) — 1782KB
• rklb-ex31_1.htm (EX-31.1) — 16KB
• rklb-ex31_2.htm (EX-31.2) — 17KB
• rklb-ex32_1.htm (EX-32.1) — 14KB
• 0000950170-24-053646.txt (&nbsp;) — 9595KB
• rklb-20240331.xsd (EX-101.SCH) — 1800KB
• rklb-20240331_htm.xml (XML) — 1750KB

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 21 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 29 Item 4.

Controls and Procedures

Controls and Procedures 29 PART II. OTHER INFORMATION 30 Item 1.

Legal Proceedings

Legal Proceedings 30 Item 1A.

Risk Factors

Risk Factors 30 Item 2. Unregistered Sales of Equity Securities 30 Item 3. Defaults Upon Senior Securities 30 Item 4. Mine Safety Disclosures 30 Item 5. Other Information 30 Item 6. Exhibits 31

Signatures

Signatures 32 4 Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ROCKET LAB U.S.A., INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS AS OF MARCH 31, 2024 AND DECEMBER 31, 2023 (in thousands, except share and per share values) March 31, 2024 (unaudited) December 31, 2023 Assets Current assets: Cash and cash equivalents $ 365,929 $ 162,518 Marketable securities, current 126,593 82,255 Accounts receivable, net 31,167 35,176 Contract assets 14,895 12,951 Inventories 99,901 107,857 Prepaids and other current assets 78,606 66,949 Assets held for sale 8,532 9,016 Total current assets 725,623 476,722 Non-current assets: Property, plant and equipment, net 148,087 145,409 Intangible assets, net 66,845 68,094 Goodwill 71,020 71,020 Right-of-use assets - operating leases 56,870 59,401 Right-of-use assets - finance leases 14,827 14,987 Marketable securities, non-current 68,566 79,247 Restricted cash 3,849 3,916 Deferred income tax assets, net 3,353 3,501 Other non-current assets 22,884 18,914 Total assets $ 1,181,924 $ 941,211 Liabilities and Stockholders' Equity Current liabilities: Trade payables $ 25,995 $ 29,303 Accrued expenses 9,091 5,590 Employee benefits payable 13,934 16,342 Contract liabilities 150,535 139,338 Current installments of long-term borrowings 10,996 17,764 Other current liabilities 21,911 15,036 Total current liabilities 232,462 223,373 Non-current liabilities: Convertible senior notes, net 343,829 — Long-term borrowings, net, excluding current installments 52,717 87,587 Non-current operating lease liabilities 54,101 56,099 Non-current finance lease liabilities 15,177 15,238 Deferred tax liabilities 530 426 Other non-current liabilities 4,162 3,944 Total liabilities 702,978 386,667 COMMITMENTS AND CONTINGENCIES (Note 15) Stockhol